Mylan Inc (NASDAQ:MYL) lived up to its leadership position in the generic drug industry by launching the first generic version of the contraceptive transdermal patch that was originally developed by Johnson & Johnson (NYSE:JNJ). Mylan Inc (NASDAQ:MYL) shares after opening at $49.86 moved to $53.57 on last trade day and at the end of the day closed at $52.10. Company price to sales ratio in past twelve months was calculated as 2.80 and price to cash ratio as 66.52. Mylan Inc (NASDAQ:MYL) showed a positive weekly performance of 11.04%.
ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, reported financial results for the three-month period ended March 31, 2014 – the third quarter of the Company’s 2014 fiscal year. ImmunoGen also provided an update on Company and partner product programs. ImmunoGen, Inc. (NASDAQ:IMGN) shares fell -10.15% in last trading session and ended the day on $12.39. IMGN return on equity ratio is recorded as -24.10% and its return on assets is -14.50%. ImmunoGen, Inc. (NASDAQ:IMGN) yearly performance is -17.51%.
Ben R. Leedle, Jr., president and chief executive officer of Healthways (NASDAQ: HWAY), announced financial results for the first quarter ended March 31, 2014. Total revenues for the quarter were $176.8 million, up 7.0% from $165.2 million for the first quarter of 2013. Healthways, Inc. (NASDAQ:HWAY) shares moved up 12.94% in last trading session and was closed at $18.16, while trading in range of $16.71-$18.73. Healthways, Inc. (NASDAQ:HWAY) year to date performance is 18.31%.
The generic drug maker Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has set 29th April as the day on which it would be reporting the earnings from its 1Q14 operations. In the run up to the earnings call, the small capped drug maker has been releasing a steady flow of news releases which highlight the new initiatives it has been taking to up its market valuation.Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) weekly performance is 2.20%. On last trading day company shares ended up $10.68. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) distance from 50-day simple moving average is -16.94%. Analysts mean target price for the company is $14.79.
Leave a Reply